9Z3J
HCoV-NL63 S2' peptide bound to TMPRSS2 S441A (complexed with the H1H7 Fab and an anti-kappa-nanobody)
Summary for 9Z3J
| Entry DOI | 10.2210/pdb9z3j/pdb |
| EMDB information | 73786 |
| Descriptor | HCoV-NL63 S2' peptide, Inactive TMPRSS2 construct, H1H7 heavy chain, ... (7 entities in total) |
| Functional Keywords | tmprss2, nl63, s2prime, coronavirus, cleavage, sars-cov-2, spike, fusion, protease, entry, antiviral, structural genomics, seattle structural genomics center for infectious disease, ssgcid, viral protein, viral protein-immune system complex, viral protein/immune system |
| Biological source | Human coronavirus NL63 More |
| Total number of polymer chains | 5 |
| Total formula weight | 124882.49 |
| Authors | McCallum, M.,Seattle Structural Genomics Center for Infectious Disease (SSGCID),Veesler, D. (deposition date: 2025-11-06, release date: 2026-05-13) |
| Primary citation | McCallum, M.,Case, J.B.,Brown, J.T.,Park, Y.J.,Lee, J.,Sutherland, E.,Aggarwal, A.,Gibson, C.,Lempp, F.A.,Stewart, C.,Tortorici, M.A.,Sanapala, S.,Low, J.S.,Asarnow, D.,Bohan, D.,Dellota Jr., E.,Merz, B.,Chawla, B.,Kar, S.,Lanzavecchia, A.,Sallusto, F.,Riley, N.M.,Turville, S.,Purcell, L.,Diamond, M.S.,Veesler, D. TMPRSS2-mediated coronavirus spike activation and inhibition. Nat.Struct.Mol.Biol., 2026 Cited by PubMed Abstract: The protease TMPRSS2 facilitates coronavirus infections, yet its mechanism of viral glycoprotein recognition remains unclear. Here we show that, following ACE2 engagement of the SARS-CoV-2 spike (S) inducing the early fusion intermediate conformation (E-FIC), TMPRSS2 cleaves the R815 S' site and promotes fusogenic conformational changes leading to viral entry. We unveil TMPRSS2 recognition of S', identify key residues modulating binding specificity and demonstrate that S' site-directed broadly neutralizing antibodies target E-FIC and inhibit viral entry by blocking TMPRSS2 access. We computationally designed stabilized E-FIC as a vaccine candidate, overcoming the transient nature of this state. We describe a TMPRSS2-directed monoclonal antibody inhibiting several coronaviruses, including SARS-CoV-2 variants and protecting mice against SARS-CoV-2 challenge. These results outline the mechanistic role of TMPRSS2 and S' site-directed antibodies in coronavirus entry. PubMed: 42050172DOI: 10.1038/s41594-026-01801-y PDB entries with the same primary citation |
| Experimental method | ELECTRON MICROSCOPY (2.8 Å) |
Structure validation
Download full validation report






